BEK.B doubled its short position on paper this week — but the real story is how little any of it means at this scale.
Estimated short interest nearly doubled in a single session on April 28, jumping from roughly 159 shares to 296. That headline figure looks alarming in percentage terms — up 87% day-on-day, nearly 98% over the week. In practice, it represents fewer than 300 shares of a stock trading around CAD $12.97. Short interest is just 0.02% of the free float. The share count involved is smaller than the average retail brokerage account. At this micro level, the swings are almost certainly noise — small trades washing through a thin lending pool — not a statement about directional conviction.
The borrow market reflects the same indifference. Cost to borrow has more than tripled since late February, climbing from under 1% to 2.64% currently. That sounds dramatic; in absolute terms it is still firmly cheap, well within the range that poses no constraint on short sellers. There is no sign of a tightening availability situation or any squeeze dynamic. The ORTEX short score of 28.3 — moderate, not elevated — reinforces the picture. The short score rank of 78th percentile within its sector suggests the score reads high relative to peers, but the raw reading is not at a level historically associated with acute stress.
The stock itself has lost about 0.9% over the past month, with the price closing at CAD $12.97 on April 28. A one-day decline of 0.23% is barely a rounding error. Earnings history shows muted reactions — the last four prints produced day-one moves of -0.9%, +2.7%, -0.4%, and -3.1%. None of those qualify as high-volatility events. The next scheduled earnings release is July 17.
Ownership is extremely concentrated. The only reported institutional holder, Euclid Securities Limited, holds nearly 30% of shares outstanding. That data is approximately one year old, so the precise figure should be treated with caution — but the structural reality of a thinly traded, closely held real estate operating company has not changed. With a free float of roughly 1.27 million shares and no analyst coverage in the data, this is a name where almost any short interest reading will look extreme in percentage-change terms while remaining trivially small in absolute size.
The dividend score of 73 is the most genuinely notable factor score in the snapshot. The last confirmed dividend was a CAD $0.40 payment in March 2022, after which the cadence appears to have stopped — no new announcements since. That lapsed income story, combined with a tightly held share register and no active analyst coverage, defines what to watch: whether the company resumes distributions, and whether any ownership disclosure updates shed light on whether Euclid has been adding or reducing.
See the live data behind this article on ORTEX.
Open BEK.B on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
